Tag: zimberelimab

Gilead Sciences invests $320m in Arcus Biosciences to accelerate cancer treatment innovations

businessnewstoday- January 30, 2024 0

Gilead Sciences, Inc. (Nasdaq: GILD) and Arcus Biosciences, Inc. (NYSE: RCUS) have announced a significant amendment to their collaboration agreement, accompanied by a substantial $320 ... Read More